Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody

Abstract Background Distinct clinical presentations of interstitial lung disease (ILD) with the myositis-specific antibodies, including anti-synthetase antibodies, are well-recognized. However, the association between ILD and the myositis-associated antibodies, including anti-Ro52, is less establish...

Full description

Bibliographic Details
Main Authors: A. Sclafani, K. M. D’Silva, B. P. Little, E. M. Miloslavsky, J. J. Locascio, A. Sharma, S. B. Montesi
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Respiratory Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12931-019-1231-7